Health Canada Approves Pembrolizumab/Surgery in Locally Advanced HNSCC
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma: Physicians are pioneering improved management techniques to mitigate toxicities that encapsulate the use of immune-checkpoint inhibitors in successful treatment procedures for Melanoma.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: The latest article analyses the FDA’s decision to put the experimental treatment SRN-101 on the fast track. It is aimed at addressing recurrent high-grade glioma, a severe type of brain cancer.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: Recent experiments reveal a novel small molecule that has shown exciting potential in treating pretreated multiple myeloma, paving way for more targeted and effective therapies.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: Researchers have conducted an in-depth comparison of the quality of life outcomes resulting from utilizing two distinctive therapies – protons and photons – in the treatment of oropharyngeal cancer.
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer: We explore three pivotal points that encompass PSMA-Directed Imaging and Radioligand Therapy in the context of Prostate Cancer, laying a foundation of understanding for patients and practitioners alike.
